{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:41:31Z","timestamp":1790228491494,"version":"4.1.0"},"reference-count":32,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The appendix contains abundant lymphoid tissue and is constantly exposed to gut flora. When completed at a young age, appendicitis followed by appendectomy (AA) prevents or significantly ameliorates Inflammatory Bowel Diseases (IBDs) in later life. Inflammatory bowel disease comprises Crohn\u2019s disease and ulcerative colitis. Our murine AA model is the only existing experimental model of AA. In our unique model, AA performed in the most proximal colon limits colitis pathology in the most distal colon by curbing T-helper 17 cell activity, diminishing autophagy, modulating interferon activity-associated molecules, and suppressing endothelin vaso-activity-mediated immunopathology. In the research presented in this paper, we have examined the role of chemokines in colitis pathology with our murine AA model. Chemokines are a family of small cytokines with four conserved cysteine residues. Chemokines induce chemotaxis in adjacent cells with corresponding receptors. All 40 known chemokine genes and 24 chemokine receptor genes were examined for gene expression levels in distal colons three days post-AA and 28 days post-AA. At 28 days post-AA, the chemokine gene CCL5 was significantly upregulated. Furthermore, Gene Set Enrichment Analysis (GSEA) showed upregulation of seven CCL5-associated gene-sets 28 days post-AA in contrast to just one gene-set downregulated at the same time-point. The chemokine gene CXCL11 was significantly upregulated three days post-AA and 28 days post-AA. Evaluation using GSEA showed upregulation of six CXCL11-associated gene sets but no downregulation of any gene set. At 28 days post-AA, CCL17 gene expression was significantly downregulated. There was no expression of any chemokine receptor gene three days post-AA, but CCR10 was the only chemokine receptor gene that displayed differential gene expression (upregulation) 28 days post-AA. No CCR10-associated gene set was upregulated in GSEA in contrast to one downregulated gene set. Our analysis resulted in identifying three new therapeutic targets towards ameliorating colitis: CCL5, CXCL11, and CCL17. While CCL5 and CXCL11 are good therapeutic chemokine candidates to be exogenously administered, CCL17 is a good candidate chemokine to competitively inhibit or limit colitis pathology.<\/jats:p>","DOI":"10.3390\/biom8030059","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T03:24:27Z","timestamp":1532316267000},"page":"59","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Role of Specific Chemokines in the Amelioration of Colitis by Appendicitis and Appendectomy"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3472-9591","authenticated-orcid":false,"given":"Rajkumar","family":"Cheluvappa","sequence":"first","affiliation":[{"name":"Department of Medicine, St. George Clinical School, University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis G.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-3574","authenticated-orcid":false,"given":"Selwyn","family":"Selvendran","sequence":"additional","affiliation":[{"name":"Department of Surgery, St. George Hospital, Kogarah, NSW 2217, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/oxfordjournals.aje.a115734","article-title":"The epidemiology of appendicitis and appendectomy in the united states","volume":"132","author":"Addiss","year":"1990","journal-title":"Am. J. Epidemiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00054725-200207000-00007","article-title":"Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: A critical review","volume":"8","author":"Koutroubakis","year":"2002","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_3","first-page":"303","article-title":"Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: A familial case-control study","volume":"93","author":"Gabriel","year":"2001","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM200103153441104","article-title":"Appendectomy and protection against ulcerative colitis","volume":"344","author":"Andersson","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.51.6.808","article-title":"Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn\u2019s disease","volume":"51","author":"Edwards","year":"2002","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1480-9222-16-10","article-title":"A novel model of appendicitis and appendectomy to investigate inflammatory bowel disease pathogenesis and remediation","volume":"16","author":"Cheluvappa","year":"2014","journal-title":"Biol. Proced. Online"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/cei.12237","article-title":"T helper type 17 pathway suppression by appendicitis and appendectomy protects against colitis","volume":"175","author":"Cheluvappa","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00384-014-1936-5","article-title":"Experimental appendicitis and appendectomy modulate the CCL20\u2013CCR6 axis to limit inflammatory colitis pathology","volume":"29","author":"Cheluvappa","year":"2014","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/MIB.0000000000000034","article-title":"Autophagy suppression by appendicitis and appendectomy protects against colitis","volume":"20","author":"Cheluvappa","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00384-014-1974-z","article-title":"Endothelin and vascular remodelling in colitis pathogenesis\u2014Appendicitis and appendectomy limit colitis by suppressing endothelin pathways","volume":"29","author":"Cheluvappa","year":"2014","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/jir.2014.0091","article-title":"Modulation of interferon activity-associated soluble molecules by appendicitis and appendectomy limits colitis-identification of novel anti-colitic targets","volume":"35","author":"Cheluvappa","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: A new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2796.2001.00867.x","article-title":"Chemokines in pathology and medicine","volume":"250","author":"Baggiolini","year":"2001","journal-title":"J. Int. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1874467210801030195","article-title":"Biologic therapies against inflammatory bowel disease: A dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key","volume":"1","author":"Dharmani","year":"2008","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/138945010790309975","article-title":"Emerging biologics in the treatment of inflammatory bowel disease: What is around the corner?","volume":"11","author":"Fiorino","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1210\/en.2008-1449","article-title":"Rhoa\/Rho kinase signaling in the cumulus mediates extracellular matrix assembly","volume":"150","author":"Yodoi","year":"2009","journal-title":"Endocrinology"},{"key":"ref_19","unstructured":"Kastin, A.J. (2013). Chapter 89\u2014Chemokines. Handbook of Biologically Active Peptides, Academic Press. [2nd ed.]."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: From bench to bedside","volume":"27","author":"Yoshie","year":"2015","journal-title":"Int. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2990.2010.01089.x","article-title":"Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity\u2014A tale of conflict and conundrum","volume":"36","author":"Muller","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.dci.2011.01.019","article-title":"A family tree of vertebrate chemokine receptors for a unified nomenclature","volume":"35","author":"Nomiyama","year":"2011","journal-title":"Dev. Comp. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2249.2011.04434.x","article-title":"Protective pathways against colitis mediated by appendicitis and appendectomy","volume":"165","author":"Cheluvappa","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1023\/B:JOCI.0000018066.46279.6b","article-title":"Increased expression of CCL20 in human inflammatory bowel disease","volume":"24","author":"Kaser","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat. Gen."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2249.2007.03463.x","article-title":"A murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents","volume":"150","author":"Hampartzoumian","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1100\/tsw.2009.57","article-title":"Minimum information about a microarray experiment (MIAME)\u2014Successes, failures, challenges","volume":"9","author":"Brazma","year":"2009","journal-title":"Sci. World J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng1201-365","article-title":"Minimum information about a microarray experiment (MIAME)-toward standards for microarray data","volume":"29","author":"Brazma","year":"2001","journal-title":"Nat. Gen."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Gen."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/8\/3\/59\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:13:23Z","timestamp":1760195603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/8\/3\/59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["biom8030059"],"URL":"https:\/\/doi.org\/10.3390\/biom8030059","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]}}}